When you buy based on the rating alone — without understanding the IF — you're not investing. You're delegating. And when the hypothesis breaks, you're the last one to know. Some questions worth asking before you act on any analyst report: → What has to be true for this thesis to work? → What's the single biggest risk that would break it? → When was this published, and has anything changed since? → How has this analyst's track record held up on similar calls? The rating is just the headline. The hypothesis is the whole story. Read both. Or don't be surprised by the ending. We built Occam's Investing to answer these questions systematically — three independent lenses on every ticker, so you see what one model alone would miss. Founding members lock in $4/mo permanently before the price moves to $20 on March 30: https://insightfulagents.ai/occams-investing.html?utm_source=linkedin&utm_medium=organic&utm_campaign=analyst-hypothesis